Natalie Henson returns to Axon
July 21, 2010Medical Communications Axon, appointment, medical communications
Surrey, UK-based communications agency Axon has appointed Natalie Henson as associate director. She re-joins the firm in a leadership role …
Pharmacologists in the vanguard of pharma R&D
July 21, 2010Business Services, Research and Development BPS, Clinical Pharmacology, pharmacology, research
The British Pharmacology Society (BPS) is the primary UK learned society concerned with research into drugs and the way they …
European Commission invests €6.4 billion in research
July 21, 2010Research and Development European Commission, research
The European Commission has announced a €6.4 billion investment in research and innovation in a range of scientific disciplines including …
Government outlines health reform goals
July 20, 2010NHS, NHS targets, government
The coalition government has proposed five areas, from increasing quality of life to preventing premature death, against which the success …
Manufacturing Q&A: Eden Biodesign
July 20, 2010Business Services, Manufacturing and Production Eden Biodesign, careers, manufacturing
How long has your company been operating? Eden Biodesign is enjoying its tenth anniversary this year. How is your field …
J&J cited by FDA for another manufacturing facility
July 20, 2010Manufacturing and Production J&J, JJ, manufacturing compliance
Another week, another raft of bad news for Johnson & Johnson’s manufacturing division. With one production facility already shut down …
Excipient problem leads to Coumadin recall
July 20, 2010Manufacturing and Production BMS, manufacturing compliance, recalls
Bristol-Myers Squibb is recalling nearly 150,000 tablets of its anticoagulant product Coumadin distributed across the US because some of them …
Pfizer forced to halt pain drug trials
July 20, 2010Research and Development Pfizer, chronic pain, pain therapeutics, tanezumab
Pfizer has been told by the FDA to suspend trials of its novel injectable biotherapeutic tanezumab for chronic low back …
Manufacturing news in brief
July 20, 2010Manufacturing and Production Apicore, Emergent, Merck & Co, PPS, Tianyin, lilly
A crop of facility announcements from Merck & Co, Emergent, Tianyin, Apicore and PPS offset more job loss news from …
Merck Millipore unveiled as $7bn acquisition completed
July 20, 2010Manufacturing and Production Merck KGaA, Millipore
Germany’s Merck KGaA has completed its $7 billion acquisition of processing equipment specialist Millipore, officially launching the combined Merck Millipore …
TBWAPaling Walters promotes Andy Hayley
July 20, 2010Medical Communications TBWA/Paling Walters, appointment, medical communications
Health communications agency TBWA\Paling Walters has promoted former client services director Andy Hayley to managing director. He will succeed company …
Bayer signs Chinese research deal
July 20, 2010Research and Development Bayer, China, gynaecology
Bayer is partnering with the People’s Liberation Army General Hospital in Beijing on research into women’s healthcare. The People’s Liberation …
Digital Pharma: Byte-sized roundup
July 19, 2010Medical Communications Amgen, Digital Pharma blog, EMA, Sermo, digital doctors, google, psoriasis
This week’s roundup includes EMA’s new look website, a psoriasis patient group’s e-commerce venture, Amgen’s online patient empowerment competition, changes …
NICE’s methods to be put under the spotlight
July 19, 2010Sales and Marketing MRC, NICE, cost-effectiveness
The Medical Research Council has awarded £2.3 million for new research into the academic methods underpinning advice given by NICE …
US approval for Sanofi’s Jevtana
July 19, 2010Sales and Marketing Jevtana, Sanofi-Aventis, chemotherapy, prostate cancer
US regulators have approved Sanofi-Aventis’ chemotherapy agent Jevtana in combination with the steroid prednisone to treat men with prostate cancer. …
Elan expects Zonegran marketing probe to cost it $206m
July 19, 2010Sales and Marketing Elan, Zonegran
Elan Corporation expects to pay $206.3 million to settle a US government investigation into the way it marketed its anti-epileptic …
UCB’s Speers to lead European Medicines Group
July 19, 2010Sales and Marketing European Medicines Group, UCB, appointment, sales and marketing
UCB Pharma’s managing director Matthew Speers has been elected chair of the European Medicines Group, taking over from Nigel Brooksby …
NICE reaffirms positive opinion on Multaq
July 19, 2010Sales and Marketing Multaq, NICE, antiarrhythmic, dronedarone
In its final draft guidance, UK cost-effectiveness body NICE has reaffirmed its previous positive opinion to recommend the limited use …
GSK takes £1.58bn hit from legal disputes
July 16, 2010Sales and Marketing Avandia, GlaxoSmithKline, Paxcil, Seroxat
GlaxoSmithKline is set to pay £1.58 billion to settle three long-standing legal disputes, including litigation costs for its troubled diabetes …
Lonza wins two biologic contracts
July 16, 2010Manufacturing and Production Elusys, Human Genome Sciences, Lonza
Swiss fine chemicals firm Lonza has secured two new contracts for its contract manufacturing division for monoclonal antibodies to treat …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
